Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers December 15, 2018
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - December 15, 2018

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

12/15/18 - Alder BioPharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) [Tehran Times (Iran)]
-Alder BioPharmaceuticals, Inc., a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today reported that the Compensation Committee of Alders Board of Directors granted a non-qualified stock option to purchase an aggregate of 270,000 shares of Alders common stock to Carlos E. Campoy under Al
12/15/18 - AstraZeneca mines for positives in Imfinzi`s failed Mystic lung cancer trial [Syrian Arab News Agency]
AstraZeneca felt the blow last month when Mystic, a key trial examining its immuno-oncology drug Imfinzi in previously untreated lung cancer, failed. As executives were quick to point out, there was clear clinical benefit of Imfinzi monotherapy compared with the standard of care in the phase 3 trial, which featured patients whose tumors expressed p
12/15/18 - BeiGene Announces Updated Phase 1A/1B Data on Tislelizumab Presented at the European Society for Medical Oncology Immuno-Oncology Congress
BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, announced that updated clinical data from an ongoing Phase 1 A/1B trial of tislelizumab, an investigational anti-PD-1 antibody, were presented in an oral...
12/15/18 - Bellicum Reports Safety Results and Promising Activity of Its Controlled CAR-T Candidate BPX-601 in Patients with Advanced Pancreatic Cancer at ESMO-IO [Tehran Times (Iran)]
-Bellicum Pharmaceuticals, Inc., a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today reported safety and promising activity of BPX-601 in Part 1 of a Phase 1/ 2 dose-escalation study in patients with advanced, metastatic pancreatic cancer expressing PSCA. Data were reviewed dur
12/15/18 - Bevacizumab Biosimilar, IBI305, Meets Primary End Points in 2 Clinical Trials [T-break Tech (Middle East)]
"Lung cancer is the highest incidence cancer in China, and bevacizumab is an important treatment for non-small lung cancer patients. The launch of a high-quality bevacizumab biosimilar will improve drug accessibility and benefit more patients, "said Li Zhang, MD, from the cancer hospital of Sun Yat-Sen University, in a statement announcing the posi
12/15/18 - Bovine Blood Plasma Derivatives Market Will Increment at a Notable CAGR of 5.8% During the Forecast Period of 2017 to 2025
Albany, NY 12/14/2018 Global Bovine Blood Plasma Derivatives Market: Snapshot. Bovine blood plasma derivatives are exclusive in a way when it comes to delivering palatability, something that cannot be achieved via other alternatives such as plant extracted proteins and other synthetic nutrient elements. The analysts of the report have evaluat
12/15/18 - Butantan Institute and MSD agree to collaborate on dengue vaccine development [T-break Tech (Middle East)]
Brazil`s Butantan Institute signed a collaboration agreement with Merck Sharp& Dohme to develop dengue vaccines. The vaccine developed by Butantan Institute with So Paulo Research Foundation- FAPESP`s support is currently in the last phase of trials involving humans, with 17,000 volunteers participating. The agreement also allows for exclusive...
12/15/18 - Cerveau Technologies, Inc. to Support a First Clinical Study in Asia of a Novel Biomarker of Alzheimers Disease [Syrian Arab News Agency]
Cerveau Technologies Inc. today announced that the Memory Aging and Cognition Centre at the National University Health System in Singapore has initiated a study with an early stage imaging agent MK-6240 to be used in Positron Emission Tomography scans for assessing the level and progression of neurofibrillary tangles in the brain.
12/15/18 - Conclusion Of A Non-exclusive Rebate Agreement Pursuant To Section 130a (8) Sgb V On Medicines Containing The Active Substance Aripiprazole As Depot Injection Suspension (atc Code: N05ax12) [TendersInfo (India)]
The aok- the health fund for lower saxony intends until the entry into force of exclusive contracts after a public tender according to the regulations of the 4th part of the gwb, non-exclusive drug discount agreements on the active ingredient aripiprazole as depot injection suspension with all possible market participants in the so-called "open-hou
12/15/18 - Conclusion Of Non-exclusive Discount Agreements Pursuant To Section 130a (8) Sgb V On Medicines Containing The Active Substance Pegfilgrastim (atc: L03aa13) As Part Of A So-called Open-house Model. [TendersInfo (India)]
For the active substance pegfilgrastim, the aok rheinland-pfalz/ saarland- die gesundheitskasse offers rebate contracts to all interested pharmaceutical companies without a selection decision for the period up to the entry into force of exclusive contracts following a formal award procedure in accordance with the regulations of the 4th part of the
12/15/18 - CYNATA Gets Major Funding From NHMRC For Second Phase Clinical Trial In Osteoarthritis [Sport360]
Australian National Health and Medical Research Council will fund a major second phase of clinical trial in osteoarthritis for CYNATA THERAPEUTICS LIMITED. Cynata being a biotechnology company has its specialization in cell therapeutics. The company has a unique Cymerus technology which deals with the complexity and challenges of manufacturing the.
12/15/18 - Diabetes Centre inaugurated at Suntreso Hospital [Syrian Arab News Agency]
A Diabetes Support Centre has been inaugurated at the Suntreso Government Hospital in Kumasi. The Danish Embassy in Ghana, facilitated the construction of the centre which was built by Novo Nordisk, a Danish pharmaceutical company with expertise in diabetes care. At a ceremony to officially open the centre, the Ashanti Regional Director of Health S
12/15/18 - Dr. Jin Kim, Internationally Influential Periodontist, Offers FDA-Cleared LANAP Laser Therapy for Periodontal Disease in Chino Hills, CA [Tehran Times (Iran)]
-Jin Y. Kim, a leading board-certified periodontist who has dedicated his career to learning and contributing to the latest in periodontal care welcomes people withperiodontal diseasein Chino Hills, CA, to take advantage of LANAP, the FDA- cleared laser gum therapy treatment he offers. When patients work with Dr. Kim to properly address their gum d
12/15/18 - DRAP fails to check corruption, unethical marketing practices by Pharma trade and industry
Drug Regulatory Authority of Pakistan which is one of the regulatory bodies and monitoring agencies to check corruption and unethical marketing practices by the pharma trade and industry has miserably failed to perform its duties. Farhat Moazam and approved by the Federal Government as well as Pakistan Medical and Dental Council many years ago but
12/15/18 - Family of Lakewood toddler with brain tumor desperate for unapproved drug []
LAKEWOOD, Colo. 2018 Elijah Gonzalez can only eat through a feeding tube. "The only drug that could really help him save his live is called tazemetostat manufactured by Epizyme," said Elijah's father Cesar Gonzalez. Yet the 41- year old Lakewood dad said the Massachusetts- based pharmaceutical company Epizyme has not been willing to make its exp
12/15/18 - Generex Biotechnology Receives IND Approval From FDA For Phase II Combination Study Using AE37 Plus Keytruda (Pembrolizumab) For The Treatment Of Triple Negative Breast Cancer [Syrian Arab News Agency]
Generex Biotechnology Corporation today announced that the FDA had reviewed the companys investigational new drug application and given notification that the study can proceed. The study: A Phase II Clinical Trial of Pembrolizumab in Combination with the AE37 Peptide Vaccine in Patients with Metastatic Triple Negative Breast Cancer, is sponsored by
12/15/18 - Government to strengthen management of drug-making plants overseas [Sport360]
The Ministry of Food and Drug Safety said Thursday that it has revised the Pharmaceutical Affairs Law to set up a basis for the registration and inspection of drug-making plants in foreign countries. The agency also mandated that such factories must provide insurance for patients participating in the clinical trials. The amendment comes after the d
12/15/18 - Greens, beans and dark chocolate to boost vitamin D
PEOPLE should eat dark, leafy greens and dark chocolate as well as taking supplements to get the proper dose of the sunshine vitamin D during the dark winter months, scientists say. Scotland has the lowest levels of vitamin D, due to a lack of sunshine and a diet low in oily fish. Research professor, Dr Martha Shrubsole, at Vanderbilt University Me
12/15/18 - Hebei Medical University Fourth Hospital Ct Double Cylinder High Pressure Syringe and Other Medical Equipment Procurement Project (International Bidding)
Company: FOURTH HOSPITAL OF HEBEI MEDICAL UNIVERSITY. 12 Health Road, Shijiazhuang City, Attn: Luolei, Tel: +86-311-86095626. Description: Project Name: Hebei Medical University fourth hospital CT double cylinder high pressure syringe and other medical equipment procurement project Tenders are invited for A Batch of Purchasing Items of Ct Double Ba
12/15/18 - Injectable Drug Delivery Market: In-Depth Evaluation on Growth, Share, Size and Trends Until the End of 20182028: Drug delivery refers to the approaches, technologies and systems used for the administration of drugs to patients.
Albany, NY 12/15/2018 In order to study the various trends and patterns prevailing in the concerned market, Market Research Reports Search Engine has included a new report titled " Injectable Drug Delivery Market" to its wide online database. This research assessment offers a clear insight about the influential factors that are expected to tr
12/15/18 - Innovent reports positive results from two trials of IBI305 [Syrian Arab News Agency]
Innovent Biologics has reported positive results from two clinical trials of IBI305 after meeting the pre-defined primary endpoints of both studies. China- based Innovents IBI305 is a biosimilar of bevacizumab, which is a recombinant humanised anti-vascular endothelial growth factor monoclonal antibody developed for use as injection.
12/15/18 - Janssen Submits Supplemental New Drug Application (sNDA) to FDA for XARELTO (rivaroxaban) to Prevent Venous Thromboembolism (VTE) in Acute Medically Ill Patients [Sport360]
The Janssen Pharmaceutical Companies of Johnson& Johnson announced today the submission of a supplemental New Drug Application for XARELTO to the U.S. Food and Drug Administration for the prevention of venous thromboembolism, or blood clots, in medically ill patients. "Despite being at high risk of VTE for up to six weeks when leaving the hospital
12/15/18 - Janssen Submits Supplemental New Drug Application to FDA for XARELTO (Rivaroxaban) to Prevent Venous Thromboembolism (VTE) in Acute Medically Ill Patients
Janssen Pharmaceutical Companies, a subsidiary of Johnson and Johnson, issued the following news release:. -If approved, this will add to the five existing VTE indications for XARELTO (R)- the most studied anticoagulant available to the most groups of patients. The Janssen Pharmaceutical Companies of Johnson& Johnson announced today the submission
12/15/18 - Magnesium Lactate Market Value Chain and Forecast 2018-2026
Rockville, MD 12/14/2018 Magnesium Lactate Market Introduction:. Magnesium lactate is a magnesium salt of lactic acid and commonly used ingredient added to food and beverages as an acidity regulator. It is also used as a dietary supplement and as a nutrient in different formulation.
12/15/18 - More local patients must be part of clinical trials in UAE [Tehran Times (Iran)]
Patients in the region, including the UAE, are consuming medication in development of which they have not been adequately represented, said experts. "A total of 57 clinical trials have been done in the UAE," said Dr Amin Al Amiri, assistant undersecretary for the Public Health Policy and Licensing Sector. Compared to Egypt and Saudi Arabia, the UA
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
Pharmacy Spanish
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement